S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
Completed · Phase 2
Conditions studied: Sarcoma
In brief
RATIONALE: Erlotinib may stop the growth of tumor cells by blocking the enzymes necessary for tumor cell growth. PURPOSE: This phase II trial is studying how well erlotinib works in treating patients with unresectable or metastatic malignant peripheral nerve sheath tumor.
Key facts
- Study ID
- NCT00068367
- Run by
- SWOG Cancer Research Network
- People needed
- 24
- Starts
- 2003-12-01
- Expected to finish
- 2009-08-01
- Last updated by the study team
- 2017-11-06
Who can join
Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of California Davis Cancer Center — Davis, California, United States
- Contra Costa Regional Medical Center — Martinez, California, United States
- St. Anthony Central Hospital — Denver, Colorado, United States
- University of Colorado Cancer Center at University of Colorado Health Sciences Center — Denver, Colorado, United States
- Montrose Memorial Hospital Cancer Center — Montrose, Colorado, United States
- St. Anthony North Hospital — Westminster, Colorado, United States
- Exempla Lutheran Medical Center — Wheat Ridge, Colorado, United States
- Piedmont Hospital — Atlanta, Georgia, United States
- CCOP - Atlanta Regional — Atlanta, Georgia, United States
- Northside Hospital Cancer Center — Atlanta, Georgia, United States
- Saint Joseph's Hospital of Atlanta — Atlanta, Georgia, United States
- WellStar Cobb Hospital — Austell, Georgia, United States
- Charles B. Eberhart Cancer Center at DeKalb Medical Center — Decatur, Georgia, United States
- Gwinnett Medical Center — Lawrenceville, Georgia, United States
- Kennestone Cancer Center at Wellstar Kennestone Hospital — Marietta, Georgia, United States
- Southern Regional Medical Center — Riverdale, Georgia, United States
- Cardinal Bernardin Cancer Center at Loyola University Medical Center — Maywood, Illinois, United States
- Regional Cancer Center at Memorial Medical Center — Springfield, Illinois, United States
- St. Francis Hospital and Health Centers — Beech Grove, Indiana, United States
- McFarland Clinic, P.C. — Ames, Iowa, United States
- Baton Rouge General Regional Cancer Center — Baton Rouge, Louisiana, United States
- Mary Bird Perkins Cancer Center - Baton Rouge — Baton Rouge, Louisiana, United States
- MBCCOP - LSU Health Sciences Center — New Orleans, Louisiana, United States
- Medical Center of Louisiana - New Orleans — New Orleans, Louisiana, United States
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences — Little Rock, Arkansas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.